e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Idiopathic pulmonary fibrosis: clinical view
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Biomarkers of fibroproliferative healing in fibrosing idiopathic interstitial pneumonias
M. Vasakova, M. Sterclova, P. Paluch, R. Matej, J. Skibova (Prague, Czech Republic)
Source:
Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Session:
Idiopathic pulmonary fibrosis: clinical view
Session type:
Poster Discussion
Number:
3381
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Vasakova, M. Sterclova, P. Paluch, R. Matej, J. Skibova (Prague, Czech Republic). Biomarkers of fibroproliferative healing in fibrosing idiopathic interstitial pneumonias. Eur Respir J 2013; 42: Suppl. 57, 3381
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Screening potential biomarkers for idiopathic pulmonary fibrosis in bronchoalveolar lavage fluid
Source: International Congress 2014 – ILDs 1
Year: 2014
BAL findings in desquamative interstitial pneumonia (DIP) and other idiopathic interstitial pneumonia (IIP)
Source: International Congress 2014 – ILDs 4
Year: 2014
Cytokine profile in bronchoalveolar lavage fluid of fibrotic idiopathic intersticial pneumonias compared to fibrotic intersticial pneumonias in connective tissue diseases
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Bronchoalveolar lavage
Source: Eur Respir Mon; 2010: 48: 59–72
Year: 2010
Analysis of inflammatory networks in interstitial lung disease in patients with rheumatoid arthritis
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Transbronchial cryobiopsy in the diagnosis of the idiopathic interstitial pneumonias
Source: International Congress 2016 – Transbronchial diagnostics: from ILD to pheripheral lesions
Year: 2016
Usefulness of bronchoalveolar lavage in the diagnosis of desquamative interstitial pneumonia
Source: International Congress 2014 – ILDs 2
Year: 2014
Impact of lymphocyte differential count in BALF on the mortality of patients with acute exacerbation of idiopathic chronic fibrosing interstitial pneumonia
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Galactomannans in bronchoalveolar lavage of patients with Idiopathic Pulmonary Fibrosis (IPF): a possible marker of disease progression.
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019
Autophagy is not impaired in BALF alveolar macrophages in IPF: Preliminary results
Source: International Congress 2014 – ILDs 3
Year: 2014
Effect of low level laser therapy in a model of pulmonary idiopathic fibrosis
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Increased apoptosis of alveolar lymphocytes (AL) in idiopathic pulmonary fibrosis (IPF). Potential mechanisms and practical considerations
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
Cytofluorimetric BAL cells characterization in IPF and in other ILD
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia
Source: Eur Respir J 2003; 22: 239-244
Year: 2003
Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis
Source: Eur Respir J 2012; 39: 352-358
Year: 2012
Investigations of broncho-alveolar lavage in children with asthma, bronchiectasis and cystic fibrosis
Source: International Congress 2015 – Paediatric bronchology
Year: 2015
Bronchoalveolar lavage in idiopathic pulmonary fibrosis
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017
Proteological assesment of idiopathic pulmonary fibrosis and hypersensitivity pneumonitis by mean of broncho-alveolar lavage
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011
Role of midkine in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept